NEW YORK (GenomeWeb) – Abbott said today that it intends to close the acquisition of Alere on Tuesday, Oct. 3, after receiving all needed regulatory clearances.

The announcement follows a flurry of activity on Thursday that saw Abbott and Alere receive clearances, some conditional, from the US Department of Justice, US Federal Trade Commission, and the US Securities and Exchange Commission.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.